Erdogan C, Balcioglu Z, Seida I, Kizilaslan D
Ulus Travma Acil Cerrahi Derg. 2024; 30(3):221-225.
PMID: 38506388
PMC: 10977500.
DOI: 10.14744/tjtes.2024.65051.
Nang S, Azad M, Velkov T, Zhou Q, Li J
Pharmacol Rev. 2021; 73(2):679-728.
PMID: 33627412
PMC: 7911091.
DOI: 10.1124/pharmrev.120.000020.
Hiremath P, Rangappa P, Jacob I, Rao K
Indian J Crit Care Med. 2018; 22(4):297-299.
PMID: 29743769
PMC: 5930534.
DOI: 10.4103/ijccm.IJCCM_418_17.
Singh R, Bhoi S, Kalita J, Misra U
Ann Indian Acad Neurol. 2017; 20(1):74-75.
PMID: 28298849
PMC: 5341275.
DOI: 10.4103/0972-2327.199908.
Kelesidis T, Falagas M
Expert Opin Drug Saf. 2015; 14(11):1687-701.
PMID: 26365594
PMC: 8082492.
DOI: 10.1517/14740338.2015.1088520.
Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria.
Dersch R, Robinson E, Beume L, Rauer S, Niesen W
Neurol Sci. 2014; 36(4):633-4.
PMID: 25501805
DOI: 10.1007/s10072-014-2031-y.
Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.
Bargiacchi O, Rossati A, Car P, Brustia D, Brondolo R, Rosa F
Infection. 2014; 42(5):801-9.
PMID: 24728736
DOI: 10.1007/s15010-014-0618-0.
An usual approach to treatment of a case of multidrug resistance Pseudomonas aeruginosa peritonitis: parenteral and intraperitoneal aminoglycosides and parenteral colistin.
May I, Abu-Khdeir M, Alexander Blackwood R
Infect Dis Rep. 2014; 4(2):e36.
PMID: 24470950
PMC: 3892633.
DOI: 10.4081/idr.2012.e36.
Colistin and polymyxin B: a re-emergence.
Gupta S, Govil D, Kakar P, Prakash O, Arora D, Das S
Indian J Crit Care Med. 2009; 13(2):49-53.
PMID: 19881183
PMC: 2772240.
DOI: 10.4103/0972-5229.56048.
Penetration of colistin into cerebrospinal fluid.
Markantonis S, Markou N, Fousteri M, Sakellaridis N, Karatzas S, Alamanos I
Antimicrob Agents Chemother. 2009; 53(11):4907-10.
PMID: 19704130
PMC: 2772309.
DOI: 10.1128/AAC.00345-09.
Management of meningitis due to antibiotic-resistant Acinetobacter species.
Kim B, Peleg A, Lodise T, Lipman J, Li J, Nation R
Lancet Infect Dis. 2009; 9(4):245-55.
PMID: 19324297
PMC: 2760093.
DOI: 10.1016/S1473-3099(09)70055-6.
Acinetobacter baumannii: emergence of a successful pathogen.
Peleg A, Seifert H, Paterson D
Clin Microbiol Rev. 2008; 21(3):538-82.
PMID: 18625687
PMC: 2493088.
DOI: 10.1128/CMR.00058-07.
Polymyxins revisited.
Landman D, Georgescu C, Martin D, Quale J
Clin Microbiol Rev. 2008; 21(3):449-65.
PMID: 18625681
PMC: 2493081.
DOI: 10.1128/CMR.00006-08.
Treatment options for multidrug-resistant Acinetobacter species.
Gilad J, Carmeli Y
Drugs. 2008; 68(2):165-89.
PMID: 18197724
DOI: 10.2165/00003495-200868020-00003.
Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome.
Yagmur R, Esen F
Crit Care. 2007; 10(6):428.
PMID: 17214907
PMC: 1794456.
DOI: 10.1186/cc5088.
Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
Katragkou A, Roilides E
J Clin Microbiol. 2005; 43(9):4916-7.
PMID: 16145177
PMC: 1234106.
DOI: 10.1128/JCM.43.9.4916-4917.2005.
Meningitis due to vancomycin-resistant Enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol.
Scapellato P, Ormazabal C, Scapellato J, Bottaro E
J Clin Microbiol. 2005; 43(7):3578-9.
PMID: 16000513
PMC: 1169172.
DOI: 10.1128/JCM.43.7.3578-3579.2005.
Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.
Arroyo L, Garcia-Curiel A, Pachon-Ibanez M, Llanos A, Ruiz M, Pachon J
J Clin Microbiol. 2005; 43(2):903-5.
PMID: 15695701
PMC: 548043.
DOI: 10.1128/JCM.43.2.903-905.2005.
